Clorox (NYSE:CLX) Price Target Raised to $159.00 at The Goldman Sachs Group

Clorox (NYSE:CLX) had its price target boosted by The Goldman Sachs Group from $141.00 to $159.00 in a report released on Tuesday, Analyst Ratings Network reports. The firm currently has a sell rating on the stock.

CLX has been the subject of several other research reports. Wells Fargo & Company upped their target price on Clorox from $155.00 to $159.00 and gave the stock an underweight rating in a research note on Tuesday, November 2nd. Morgan Stanley cut their target price on Clorox from $160.00 to $154.00 and set an underweight rating for the company in a research note on Wednesday, October 13th. Barclays cut their target price on Clorox from $138.00 to $131.00 and set an underweight rating for the company in a research note on Wednesday, November 3rd. Deutsche Bank Aktiengesellschaft upped their target price on Clorox from $156.00 to $160.00 and gave the stock a hold rating in a research note on Tuesday, November 2nd. Finally, DA Davidson increased their price objective on Clorox from $145.00 to $162.00 and gave the company a neutral rating in a research note on Tuesday, November 2nd. Seven research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of Hold and a consensus price target of $170.41.

CLX stock opened at $186.60 on Tuesday. The company has a current ratio of 0.69, a quick ratio of 0.39 and a debt-to-equity ratio of 3.45. The company’s 50 day moving average is $171.51 and its 200 day moving average is $170.33. The stock has a market cap of $22.93 billion, a price-to-earnings ratio of 53.93, a price-to-earnings-growth ratio of 4.76 and a beta of 0.21. Clorox has a 1-year low of $156.23 and a 1-year high of $231.11.

Clorox (NYSE:CLX) last issued its earnings results on Sunday, October 31st. The company reported $1.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.03 by $0.18. The business had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.70 billion. Clorox had a return on equity of 84.70% and a net margin of 6.04%. Clorox’s revenue for the quarter was down 5.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.22 earnings per share. As a group, sell-side analysts forecast that Clorox will post 5.46 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 11th. Investors of record on Wednesday, January 26th will be issued a dividend of $1.16 per share. The ex-dividend date is Tuesday, January 25th. This represents a $4.64 dividend on an annualized basis and a dividend yield of 2.49%. Clorox’s dividend payout ratio is presently 134.10%.

In related news, SVP Diego J. Barral sold 240 shares of the company’s stock in a transaction that occurred on Tuesday, November 16th. The stock was sold at an average price of $170.00, for a total transaction of $40,800.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.58% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently bought and sold shares of the business. Dark Forest Capital Management LP bought a new position in Clorox in the third quarter worth $25,000. Eagle Bay Advisors LLC bought a new position in Clorox in the third quarter worth $26,000. Stephenson National Bank & Trust bought a new position in Clorox in the third quarter worth $33,000. BerganKDV Wealth Management LLC raised its holdings in Clorox by 6,150.0% in the third quarter. BerganKDV Wealth Management LLC now owns 250 shares of the company’s stock worth $41,000 after purchasing an additional 246 shares in the last quarter. Finally, Tompkins Financial Corp bought a new position in shares of Clorox during the third quarter valued at $47,000. Institutional investors and hedge funds own 76.81% of the company’s stock.

About Clorox

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Cleaning, Lifestyle, Household, and International. The Cleaning segment consists of laundry, home care, and professional products marketed and sold in the United States.

Featured Story: Why do companies issue monthly dividends?

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.